Methods to modulate conditions mediated by the CXCR4 receptor
US7414065B2 · kind B2 · utility
19Cited by
5References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 17, 2004 |
| Grant date | Aug 19, 2008 |
| Priority date | — |
| Expiry date | Nov 17, 2024 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D471/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is drawn to novel antiviral compounds, pharmaceutical compositions and their use. More specifically this invention is drawn to derivatives of monocyclic polyamines which have activity in standard tests against HIV- or FIV-infected cells as well as other biological activity related to binding of ligands to chemokine receptors that mediate a number of mammalian embryonic developmental processes.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.